SVG Sprites

Press

LDPN in the News 05.21.2020

AstraZeneca secures orders for virus vaccine under testing

Minneapolis Star Tribune – 5/21/20

Margarida Jorge, the campaign director of the pressure group, Lower Drug Prices Now, challenged the decision of U.S. authorities to hand over money for the vaccine development. Jorge said the U.S. Congress should insist that any drugs developed with taxpayer investments be provided at no additional cost.

“Beating COVID depends on ensuring these medicines will be affordable,” Jorge said in a statement. “Instead, the Trump Administration continues to give drug corporations monopoly control over prices to profiteer off the pandemic.”

Press Releases 05.21.2020

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on the news that the U.S. paid AstraZeneca $1.2 billion for a billion doses of its experimental COVID vaccine:

“It’s Groundhog Day. Another day, another drug corporation with a history of price gouging gets a massive gift of taxpayer dollars, no strings attached. Every taxpayer should be asking the Trump Administration why we are giving AstraZeneca over $1 billion for drugs that were developed with our tax dollars.”

LDPN in the News 05.20.2020

Reps. Gwen Moore, Donna Edwards Joined Wisconsin Leaders to Demand Affordable COVID Treatments & Vaccines

Wednesday, May 20, 2020

Washington – Today, the Lower Drug Prices Now coalition hosted a tele-town hall featuring Wisconsin Representative Gwen Moore, former Representative Donna Edwards, Stephanie Bloomingdale, President of the Wisconsin AFL-CIO, and Gary Mitchell, President of the Wisconsin Alliance of Retired Americans to demand affordable COVID drugs and accountability for drug corporations that are profiteering off of the coronavirus pandemic.

Press Releases 05.20.2020

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on news from the World Health Assembly on a Public Good Vaccine:

“Today’s worldwide pandemic should remind us all that we are linked in an international economy where we may all be impacted by developments in nations thousands of miles away. The United States has had a long legacy of global leadership in many areas, but President Trump’s current posture on coronavirus medicines has so far been disappointing, both at home and abroad.”

Press Releases 05.19.2020

STATEMENT FROM MARGARIDA JORGE, CAMPAIGN DIRECTOR, LOWER DRUG PRICES NOW, ON THE WHITE HOUSE’S HANDLING OF TAXPAYER DOLLARS GOING TOWARDS DRUG CORPORATIONS

“This White House seems to have an open spigot of taxpayer dollars going to drug corporations that profiteer off of pandemics. They’re gearing up to give the largest award in history to a corporate executive who quintupled the price of naloxone in the middle of the opioid epidemic. Yet again, the administration is handing over taxpayer dollars away to a drug corporation with no strings attached and no guarantee that we’ll get affordable access to the medicines developed with our money. Congress must step in and take action now.”

LDPN in the News 05.19.2020

Dubious history for leader of new made-in-America drug venture

Politico – 5/19/20

“Skeptics swiftly questioned bestowing a massive BARDA grant on a startup run by Edwards.

“They’re gearing up to give the largest award in history to a corporate executive who quintupled the price of naloxone in the middle of the opioid epidemic,” said Margarida Jorge, campaign director for Lower Drug Prices Now. “Yet again, the administration is handing over taxpayer dollars away to a drug corporation with no strings attached and no guarantee that we’ll get affordable access to the medicines developed with our money.”

LDPN in the News 05.19.2020

CEO tapped by Trump to make generics during pandemic has dicey record

Stat News – 5/19/20

“But one consumer advocate, Margarida Jorge, campaign director for Lower Drug Prices Now, slammed the decision.

“This White House seems to have an open spigot of taxpayer dollars going to drug corporations that profiteer off pandemics. They’re gearing up to give the largest award in history to a corporate executive who quintupled the price of (an overdose antidote) in the middle of the opioid epidemic,” she said. “Yet again, the administration is handing over taxpayer dollars to a drug corporation with no strings attached and no guarantee that we’ll get affordable access to the medicines developed with our money.”

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles